Learn more at LeadIQ.com

Insights

Leadership Expansion BridgeBio has made strategic hires of key personnel like Yong (Ben) Ben and Thomas Trimarchi, indicating a focus on strengthening leadership to drive growth and innovation.

Substantial Financial Backing With significant funding from Norges Bank and Blue Owl Capital, totaling over $1.2 billion, BridgeBio has the financial resources to invest in new projects and expand its research capabilities, presenting partnership and investment opportunities.

Market Expansion through Spinout The launch of BridgeBio Oncology Therapeutics and the development of a KRAS-focused oncology portfolio represent market expansion initiatives, offering potential collaborations for pharmaceutical companies looking to tap into precision oncology treatments.

Innovative Technology Stack BridgeBio leverages advanced technologies like SAS, Docker, and Nuxt.js, signaling a commitment to cutting-edge solutions in drug development. This tech-driven approach opens avenues for technology partnerships and integrations within the biotechnology sector.

Revenue Growth Potential With reported revenues in the range of $50-100 million and a strong focus on genetic disease treatments, BridgeBio demonstrates growth potential in a niche market. Exploring collaboration opportunities to expand product offerings can further accelerate revenue growth.

Similar companies to BridgeBio

BridgeBio Tech Stack

BridgeBio uses 8 technology products and services including SAS, Docker, Google Docs, and more. Explore BridgeBio's tech stack below.

SAS
Business Intelligence
Docker
Containerization
Google Docs
Documentation Tools
Nuxt.js
Javascript Frameworks
Buildout
Real Estate Marketing
Yoast SEO
Search Engines
Bitbucket
Source Code Management
Envoy
Web And Application Servers

Media & News

BridgeBio's Email Address Formats

BridgeBio uses at least 1 format(s):

BridgeBio Email Formats	Example	Percentage
First.Last@bridgebio.com	John.Doe@bridgebio.com	84%
FL@bridgebio.com	JD@bridgebio.com	8%
FLast@bridgebio.com	JDoe@bridgebio.com	5%
Last@bridgebio.com	Doe@bridgebio.com	3%

Frequently Asked Questions

Where is BridgeBio's headquarters located?

BridgeBio's main headquarters is located at 421 Kipling St Palo Alto, California US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is BridgeBio's stock symbol?

BridgeBio is a publicly traded company; the company's stock symbol is BBIO.

What is BridgeBio's official website and social media links?

BridgeBio's official website is bridgebio.com and has social profiles on LinkedIn.

How much revenue does BridgeBio generate?

As of September 2024, BridgeBio's annual revenue reached $75M.

What is BridgeBio's SIC code NAICS code?

BridgeBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BridgeBio have currently?

As of September 2024, BridgeBio has approximately 660 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio: M. O.Chief Executive Officer, Ml Bio Solutions: C. S.Chief Regulatory Affairs Officer: A. N.. Explore BridgeBio's employee directory with LeadIQ.

What industry does BridgeBio belong to?

BridgeBio operates in the Biotechnology Research industry.

What technology does BridgeBio use?

BridgeBio's tech stack includes SASDockerGoogle DocsNuxt.jsBuildoutYoast SEOBitbucketEnvoy.

What is BridgeBio's email format?

BridgeBio's email format typically follows the pattern of . Find more BridgeBio email formats with LeadIQ.

How much funding has BridgeBio raised to date?

As of September 2024, BridgeBio has raised $250M in funding. The last funding round occurred on Mar 05, 2024 for $250M.

When was BridgeBio founded?

BridgeBio was founded in 2014.

BridgeBio

BridgeBio

Biotechnology ResearchCalifornia, United States501-1000 Employees

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.

Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.

BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.

Company Overview

Headquarters: 421 Kipling St Palo Alto, California US
Website: bridgebio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: BBIO
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 501-1000

Media & News

Funding & Financials

$250M
BridgeBio has raised a total of $250M of funding over 13 rounds. Their latest funding round was raised on Mar 05, 2024 in the amount of $250M.
$50M$100M
BridgeBio's revenue is in the range of $50M$100M

Funding & Financials

$250M
BridgeBio has raised a total of $250M of funding over 13 rounds. Their latest funding round was raised on Mar 05, 2024 in the amount of $250M.
$50M$100M
BridgeBio's revenue is in the range of $50M$100M

Company Leadership

M. O.
Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. S.
Chief Executive Officer, Ml Bio Solutions
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. N.
Chief Regulatory Affairs Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. W.
Chief Legal Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Chief People Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. O.
Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. L.
Chief People Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. T.
President And Chief Operating Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. H.
Chief Clinical Operations Officer
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. T.
Ceo, Skeletal Dysplasias (qed Therapeutics)
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for BridgeBio and Millions of Other Companies
Sign up for full access to BridgeBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.